Skip to Content

What is the difference between Mvasi and Avastin?

Answers (1)

Official Answer by 10 Oct 2017

Amgen’s Mvasi (bevacizumab-awwb) is a biosimilar to Genentech’s Avastin (bevacizumab).

A biosimilar, according to the FDA, is a biological product that is highly similar to an FDA-approved biological product, known as a reference product (in this case Avastin), and has no clinically meaningful differences in terms of safety and effectiveness.

Both biologics are indicated for multiple types of cancer, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, brain cancer (glioblastoma), metastatic renal cell carcinoma (kidney cancer) and cervical cancers. Mvasi is not an interchangeable product with Avastin; the physician must write a prescription specifically for it.

See also: free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 11 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 8 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 8 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 7 days ago 1 answerFAQ by